Please enable JavaScript to continue using this application.

Compare $TSHA vs $TYRA | Chartloom

Compare

$TSHA vs $TYRA

Taysha Gene Therapies Inc · Tyra Biosciences Inc

TSHA

Taysha Gene Therapies Inc

TYRA

Tyra Biosciences Inc

Compare $TSHA vs $TYRA

Comparing Taysha Gene Therapies Inc and Tyra Biosciences Inc

TSHATaysha Gene Therapies Inc

TYRATyra Biosciences Inc

TSHATaysha Gene Therapies Inc

Market cap

$1.44B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

664.56x

Rev growth (TTM)

-32.3%

YTD performance

-14.5%

52W performance

-11.3%

FCF yield

-9.2%

TYRATyra Biosciences Inc

Market cap

$1.19B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-25.6%

52W performance

46.3%

FCF yield

-9.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TSHA

TYRA

Detailed metrics comparison

TSHA

Taysha Gene Therapies Inc

TYRA

Tyra Biosciences Inc

Market Cap

TSHA$1.44B

TYRA$1.19B

Enterprise Value

TSHA$1.03B

TYRA$1.11B

Price

TSHA$4.49

TYRA$19.94

P/E Ratio

TSHAN/A

TYRAN/A

P/S Ratio

TSHA261.77x

TYRA0.00x

EV/Sales

TSHA187.75x

TYRA0.00x

EV/EBITDA

TSHA0.00x

TYRA0.00x

P/B Ratio

TSHA3.90x

TYRA3.97x

P/FCF Ratio

TSHAN/A

TYRAN/A

EV/FCF

TSHA-7.77x

TYRA-10.12x

PEG Ratio

TSHAN/A

TYRAN/A

Forward P/E (NTM)

TSHAN/A

TYRAN/A

Forward P/S (NTM)

TSHA664.56x

TYRAN/A

Revenue (TTM)

TSHA$5M

TYRA$0

Revenue Growth (YoY)

TSHA-32.3%

TYRAN/A

Forward Rev Growth

TSHA1272.3%

TYRA680.8%

Gross Margin (TTM)

TSHA0.0%

TYRA0.0%

Operating Margin (TTM)

TSHA0.0%

TYRA0.0%

EBITDA Margin (TTM)

TSHA-2833.6%

TYRA0.0%

Net Margin (TTM)

TSHA-2728.0%

TYRA0.0%

FCF Margin (TTM)

TSHA-2417.0%

TYRAN/A

Net Income (TTM)

TSHA$-150M

TYRA$-149M

FCF (TTM)

TSHA$-133M

TYRA$-110M

EPS (TTM)

TSHA-$0.41

TYRA-$2.25

ROE (TTM)

TSHA-5619.0%

TYRA-4639.0%

ROA (TTM)

TSHA-4184.0%

TYRA-4307.0%

ROIC (TTM)

TSHA-4729.0%

TYRA-4639.0%

Cash

TSHA$455M

TYRA$74M

Debt

TSHA$49M

TYRA$0

Net Cash/Debt

TSHA$406M

TYRA$74M

Current Ratio (TTM)

TSHA17.76x

TYRA14.91x

Quick Ratio (TTM)

TSHA17.57x

TYRA14.48x

Debt/Equity (TTM)

TSHA0.13x

TYRA0.00x

Debt/Assets (TTM)

TSHA0.0%

TYRA0.0%

Interest Coverage (TTM)

TSHAN/A

TYRAN/A

Net Debt/EBITDA (TTM)

TSHA0.00x

TYRA0.00x

Beta

TSHA1.37

TYRA0.65

52W Performance

TSHA-11.3%

TYRA46.3%

YTD Performance

TSHA-14.5%

TYRA-25.6%

% from 52W High

TSHA-38.5%

TYRA-50.9%

% from 52W Low

TSHA21.6%

TYRA50.0%

Asset Turnover (TTM)

TSHA0.04x

TYRA0.00x

FCF Yield (TTM)

TSHA-9.2%

TYRA-9.3%

Earnings Yield (TTM)

TSHA-10.4%

TYRA-12.5%

Dividend Yield (TTM)

TSHAN/A

TYRAN/A

Rule of 40

TSHA-2,449.3

TYRA0.0

EV/GP/RG

TSHAN/A

TYRAN/A

Ticker research

View TSHA research View TYRA research

Metric	TSHA Taysha Gene Therapies Inc	TYRA Tyra Biosciences Inc
Market & Valuation
Market Cap	$1.44B	$1.19B
Enterprise Value	$1.03B	$1.11B
Price	$4.49	$19.94
P/E Ratio	N/A	N/A
P/S Ratio	261.77x	0.00x
EV/Sales	187.75x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.90x	3.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.77x	-10.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	664.56x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-32.3%	N/A
Forward Rev Growth	1272.3%	680.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2833.6%	0.0%
Net Margin (TTM)	-2728.0%	0.0%
FCF Margin (TTM)	-2417.0%	N/A
Net Income (TTM)	$-150M	$-149M
FCF (TTM)	$-133M	$-110M
EPS (TTM)	-$0.41	-$2.25
ROE (TTM)	-5619.0%	-4639.0%
ROA (TTM)	-4184.0%	-4307.0%
ROIC (TTM)	-4729.0%	-4639.0%
Financial Health
Cash	$455M	$74M
Debt	$49M	$0
Net Cash/Debt	$406M	$74M
Current Ratio (TTM)	17.76x	14.91x
Quick Ratio (TTM)	17.57x	14.48x
Debt/Equity (TTM)	0.13x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.65
52W Performance	-11.3%	46.3%
YTD Performance	-14.5%	-25.6%
% from 52W High	-38.5%	-50.9%
% from 52W Low	21.6%	50.0%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-9.2%	-9.3%
Earnings Yield (TTM)	-10.4%	-12.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,449.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View TSHA research	View TYRA research

Valuation

P/S Ratio

TYRA

0.00x

TSHA

261.77x

EV/FCF

TYRA

-10.12x

TSHA

-7.77x

Growth & revenue

Revenue Growth TTM

TSHA

-32.3%

Forward Revenue Growth

TSHA

1272.3%

TYRA

680.8%

Profitability & performance

Gross Margin

TSHA

0.0%

TYRA

0.0%

ROE

TYRA

-4639.0%

TSHA

-5619.0%

FCF Yield %

TSHA

-9.2%

TYRA

-9.3%

52-Week Performance

TYRA

46.3%

TSHA

-11.3%

Detailed metrics comparison

TSHA

Taysha Gene Therapies Inc

TYRA

Tyra Biosciences Inc

Market Cap

TSHA$1.44B

TYRA$1.19B

Enterprise Value

TSHA$1.03B

TYRA$1.11B

Price

TSHA$4.49

TYRA$19.94

P/E Ratio

TSHAN/A

TYRAN/A

P/S Ratio

TSHA261.77x

TYRA0.00x

EV/Sales

TSHA187.75x

TYRA0.00x

EV/EBITDA

TSHA0.00x

TYRA0.00x

P/B Ratio

TSHA3.90x

TYRA3.97x

P/FCF Ratio

TSHAN/A

TYRAN/A

EV/FCF

TSHA-7.77x

TYRA-10.12x

PEG Ratio

TSHAN/A

TYRAN/A

Forward P/E (NTM)

TSHAN/A

TYRAN/A

Forward P/S (NTM)

TSHA664.56x

TYRAN/A

Revenue (TTM)

TSHA$5M

TYRA$0

Revenue Growth (YoY)

TSHA-32.3%

TYRAN/A

Forward Rev Growth

TSHA1272.3%

TYRA680.8%

Gross Margin (TTM)

TSHA0.0%

TYRA0.0%

Operating Margin (TTM)

TSHA0.0%

TYRA0.0%

EBITDA Margin (TTM)

TSHA-2833.6%

TYRA0.0%

Net Margin (TTM)

TSHA-2728.0%

TYRA0.0%

FCF Margin (TTM)

TSHA-2417.0%

TYRAN/A

Net Income (TTM)

TSHA$-150M

TYRA$-149M

FCF (TTM)

TSHA$-133M

TYRA$-110M

EPS (TTM)

TSHA-$0.41

TYRA-$2.25

ROE (TTM)

TSHA-5619.0%

TYRA-4639.0%

ROA (TTM)

TSHA-4184.0%

TYRA-4307.0%

ROIC (TTM)

TSHA-4729.0%

TYRA-4639.0%

Cash

TSHA$455M

TYRA$74M

Debt

TSHA$49M

TYRA$0

Net Cash/Debt

TSHA$406M

TYRA$74M

Current Ratio (TTM)

TSHA17.76x

TYRA14.91x

Quick Ratio (TTM)

TSHA17.57x

TYRA14.48x

Debt/Equity (TTM)

TSHA0.13x

TYRA0.00x

Debt/Assets (TTM)

TSHA0.0%

TYRA0.0%

Interest Coverage (TTM)

TSHAN/A

TYRAN/A

Net Debt/EBITDA (TTM)

TSHA0.00x

TYRA0.00x

Beta

TSHA1.37

TYRA0.65

52W Performance

TSHA-11.3%

TYRA46.3%

YTD Performance

TSHA-14.5%

TYRA-25.6%

% from 52W High

TSHA-38.5%

TYRA-50.9%

% from 52W Low

TSHA21.6%

TYRA50.0%

Asset Turnover (TTM)

TSHA0.04x

TYRA0.00x

FCF Yield (TTM)

TSHA-9.2%

TYRA-9.3%

Earnings Yield (TTM)

TSHA-10.4%

TYRA-12.5%

Dividend Yield (TTM)

TSHAN/A

TYRAN/A

Rule of 40

TSHA-2,449.3

TYRA0.0

EV/GP/RG

TSHAN/A

TYRAN/A

Ticker research

View TSHA research View TYRA research

Metric	TSHA Taysha Gene Therapies Inc	TYRA Tyra Biosciences Inc
Market & Valuation
Market Cap	$1.44B	$1.19B
Enterprise Value	$1.03B	$1.11B
Price	$4.49	$19.94
P/E Ratio	N/A	N/A
P/S Ratio	261.77x	0.00x
EV/Sales	187.75x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.90x	3.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.77x	-10.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	664.56x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-32.3%	N/A
Forward Rev Growth	1272.3%	680.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2833.6%	0.0%
Net Margin (TTM)	-2728.0%	0.0%
FCF Margin (TTM)	-2417.0%	N/A
Net Income (TTM)	$-150M	$-149M
FCF (TTM)	$-133M	$-110M
EPS (TTM)	-$0.41	-$2.25
ROE (TTM)	-5619.0%	-4639.0%
ROA (TTM)	-4184.0%	-4307.0%
ROIC (TTM)	-4729.0%	-4639.0%
Financial Health
Cash	$455M	$74M
Debt	$49M	$0
Net Cash/Debt	$406M	$74M
Current Ratio (TTM)	17.76x	14.91x
Quick Ratio (TTM)	17.57x	14.48x
Debt/Equity (TTM)	0.13x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.65
52W Performance	-11.3%	46.3%
YTD Performance	-14.5%	-25.6%
% from 52W High	-38.5%	-50.9%
% from 52W Low	21.6%	50.0%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-9.2%	-9.3%
Earnings Yield (TTM)	-10.4%	-12.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,449.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View TSHA research	View TYRA research